share_log

アステラス製薬:無形資産の減損損失 条件付対価に関わる公正価値変動額の計上 通期業績予想の修正について

Astellas Pharma: Revision of full-year earnings forecasts with recorded fair value fluctuations relating to conditional compensation for impairment losses of intangible assets

JPX ·  Apr 12, 2024 15:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more